1 (Image 01)
Roflumilast Tablet
Product Images NDC 43547-005
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 43547-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Us, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2 (Image 02)
This text appears to be a table showing recommendations and cautions for using Roflumilast and Roflumilast N-oxide in combination with other medications. The table suggests caution when using Roflumilast with medications such as Cimetidine, Enoxacin, Fluvoxamine, Ketoconazole, Minulet, Erythromycin, while some medications such as Budesonide, Digoxin, Formoterol, Maalox, Midazolam, Montelukast, Salbutamol, Sildenafit, Theophyliine, and Warfarin might not require any dosage adjustments. Rifampicin, on the other hand, is not recommended to be used with Roflumilast. The table also shows the Fold Change in Cmax and AUC Relative to Reference for each medication.*
500 Mcg 30 Tablets (Image 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
